Human embryo kidney cell line capable of stably expressing ruminant SLAM protein as well as construction method and application of human embryo kidney cell line
By constructing a 293T cell line that stably expresses SLAM protein in ruminant, the problem of difficulty in efficiently mediating PPRV infection and proliferation in the prior art is solved, and the stable expression of SLAM protein and efficient viral titer are achieved, which is suitable for the application of vaccines and diagnostic reagents. .
Patent Information
- Application Number
- CN202411468732.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-21
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-10-21
AI Technical Summary
The prior art is difficult to construct a cell line that stably expresses the SLAM protein of ruminants and efficiently mediates PPRV infection and proliferation, resulting in difficulties in epidemiological research and vaccine development.
By downloading the SLAM gene from the ruminant whole gene database, introducing the HA tag, and ligating it to the CD513B-Cherry lentiviral vector, DH5α cells were transformed, and lentiviral vector plasmid was obtained, and 293T cells were subsequently co-transfected with the helper plasmid to build stable Human renal epithelial cell line expressing ruminant SLAM protein.
Successfully constructed a 293T cell line that stably expresses the SLAM protein of ruminants, significantly improving the infection and proliferation efficiency of PPRV, increasing the virus titer by 100 times, having good genetic stability and easy cultivation, suitable for scientific research and vaccine production .
Smart Images

Figure CN119040271A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of genetic engineering, and in particular to a human embryonic kidney cell line stably expressing ruminant SLAM protein, and a construction method and application thereof. Background Art
[0002] Peste des petits ruminants (PPR) is a highly contagious viral disease of small ruminants caused by Peste des petits ruminants virus (PPRV), which causes great harm to the health of economic animals such as goats and sheep and wild ruminants such as blue sheep and white-tailed deer. The Food and Agriculture Organization of the United Nations and the World Organization for Animal Health have identified PPR as a disease to be eradicated globally. Epidemiological research and vaccine development of PPRV are the two most important parts of preventing, controlling and eradicating PPR. Cell lines are needed for both virus isolation involved in epidemiological research and strain propagation involved in vaccine development.
[0003] The receptor of peste des petits ruminants virus is SLAM, and the SLAM of its natural host ruminants can effectively mediate PPRV infection and proliferation. However, it is a technical problem to construct a cell line that stably expresses multiple ruminant SLAMs, and the currently known construction methods are difficult to construct a cell line that stably expresses SLAM proteins and efficiently mediates PPRV infection and proliferation. Therefore, it is urgent to develop a method for constructing a cell line that can stably express ruminant SLAM proteins and efficiently mediate PPRV infection and proliferation. Summary of the invention
[0004] In order to develop a method for constructing a cell line that can stably express ruminant SLAM protein and efficiently mediate PPRV infection and proliferation, the present invention provides a 293T cell line that stably expresses ruminant SLAM protein and a construction method and application thereof. The present invention successfully constructs a cell line that stably expresses ruminant SLAM protein, can significantly mediate PPRV infection and proliferation, and has the potential to be used for vaccine preparation.
[0005] The present invention provides a method for constructing a 293T cell line stably expressing a ruminant SLAM protein, comprising the following steps:
[0006] Download the SLAM gene of the desired ruminant from the ruminant gene database, introduce the HA tag at the 3' end of the SLAM gene to obtain the SLAM-HA target gene, then connect the SLAM-HA target gene to the CD513B-Cherry lentiviral vector, transform DH5α competent cells, extract the positive plasmid to obtain the lentiviral vector plasmid;
[0007] The CD513B-Cherry lentiviral vector construction process is: replacing the GFP fluorescent reporter gene of the CD513B plasmid with the Cherry fluorescent reporter gene, and adding the HTLV promoter in front of the Cherry gene to obtain the CD513B-Cherry lentiviral vector;
[0008] The obtained lentiviral vector plasmid was mixed with auxiliary plasmids pMDLg / pRRE, pRSV-Rev, and pMD2.G, and co-transfected into 293T cells to obtain packaged SLAM lentivirus;
[0009] A human renal epithelial cell line stably expressing ruminant SLAM protein was obtained by transducing SLAM lentivirus into human renal epithelial cells.
[0010] Furthermore, the construction process of the lentiviral vector plasmid is as follows: using the lentiviral vector CD513B-Cherry as a template, amplifying fragment 1 with the upstream primer shown in SEQ ID NO.13 and the downstream primer shown in SEQ ID NO.14; amplifying fragment 3 with the upstream primer shown in SEQ ID NO.15 and the downstream primer shown in SEQ ID NO.16;
[0011] Then, the fragment 1, the SLAM-HA target gene and the fragment 3 were fused by using the fusion PCR technology, so that the SLAM-HA target gene was connected to the lentiviral vector CD513B-Cherry, and the DH5α competent cells were transformed, and the positive plasmid was extracted to obtain the lentiviral vector plasmid.
[0012] Furthermore, the ruminant is any one of Java mouse deer, giraffe, musk deer, white-tailed deer, American antelope and goat.
[0013] Furthermore, the SLAM gene sequence of the Javan mouse deer is shown in SEQ ID NO.1, and the amino acid sequence of the protein encoded by it is shown in SEQ ID NO.7;
[0014] The SLAM gene sequence of the giraffe is shown in SEQ ID NO.2, and the amino acid sequence of the protein encoded by it is shown in SEQ ID NO.8;
[0015] The SLAM gene sequence of the forest musk deer is shown in SEQ ID NO.3, and the amino acid sequence of the protein encoded by it is shown in SEQ ID NO.9;
[0016] The SLAM gene sequence of the white-tailed deer is shown in SEQ ID NO.4, and the amino acid sequence of the protein encoded by it is shown in SEQ ID NO.10;
[0017] The SLAM gene sequence of the American antelope is shown in SEQ ID NO.5, and the amino acid sequence of the protein encoded by it is shown in SEQ ID NO.11;
[0018] The goat SLAM gene sequence is shown as SEQ ID NO.6, and the amino acid sequence of the protein encoded by the gene is shown as SEQ ID NO.12.
[0019] Furthermore, when the ruminant is a Javan mouse deer, the primer pair for amplifying its SLAM-HA target gene is shown as SEQ ID NO.23-SEQ ID NO.24;
[0020] When the ruminant is a giraffe, the primer pair for amplifying its SLAM-HA target gene is shown as SEQ ID NO.19-SEQ ID NO.20;
[0021] When the ruminant is musk deer, the primer pair for amplifying its SLAM-HA target gene is shown in SEQ ID NO.27-SEQ ID NO.28;
[0022] When the ruminant is a white-tailed deer, the primer pair for amplifying its SLAM-HA target gene is shown as SEQ ID NO.21-SEQ ID NO.22;
[0023] When the ruminant is an American antelope, the primer pair for amplifying its SLAM-HA target gene is shown as SEQ ID NO.25-SEQ ID NO.26;
[0024] When the ruminant is a goat, the primer pair for amplifying its SLAM-HA target gene is shown as SEQ ID NO.17-SEQ ID NO.18.
[0025] Furthermore, the SLAM lentivirus packaging process is as follows: the obtained lentiviral vector plasmid is mixed with the auxiliary plasmids pMDLg / pRRE, pRSV-Rev, and pMD2.G in a ratio of 3:1:1:1 to obtain a plasmid mixture, and the plasmid mixture is then mixed with the transfection reagent TurboFact and incubated, and then the cell culture medium is discarded, washed with serum-free Opti-MEM culture medium, and then 1 mL 2% FBSDMEM is added, the incubated plasmid mixture is transfected and packaged and cultured, the culture fluid is collected, centrifuged, and the supernatant is collected to obtain the packaged SLAM lentivirus.
[0026] Furthermore, the usage ratio of the plasmid mixture to the transfection reagent TurboFact is 3ug:6μL.
[0027] Furthermore, the centrifugation condition is: centrifugation at 4°C for 10 min.
[0028] The present invention provides a SLAM lentivirus, wherein the SLAM lentivirus is packaged by the SLAM lentivirus in the above method.
[0029] The present invention also provides a use of the SLAM lentivirus in preparing a PPR diagnostic reagent and / or vaccine.
[0030] Compared with the prior art, the present invention has the following beneficial effects:
[0031] 1. The method provided by the present invention constructs a cell line that stably expresses the SLAM proteins of Java mouse deer, giraffe, forest musk deer, white-tailed deer, American antelope and goat, and proves the efficiency of SLAM-mediated PPRV infection and proliferation of Java mouse deer, giraffe, forest musk deer, white-tailed deer, American antelope and goat. Compared with cells that do not express SLAM, HEK-293T expressing these six ruminant SLAMs can significantly mediate the infection and proliferation of PPRV. First, the pathological changes caused by PPRV in 293T-Slam cell line are more obvious than those caused by 293T-Cherry cell line, and second, the virus titer in 293T-Slam cell line is about 100 times higher than that in 293T-Cherry cell line.
[0032] 2. The lentiviral system is used to stably integrate the ruminant Slam gene into the 293T cell genome chromosome, making it genetically stable and not easily lost. The constructed 293T-Slam cell line grows fast and is easy to culture. In addition to meeting the small-scale use required for scientific research, it can also meet the large-scale use in vaccine production. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0034] Figure 1 This is a plasmid map of the lentiviral vector constructed and obtained in Example 1 of the present invention;
[0035] In the figure, A is a map of the lentiviral vector plasmid CD513B-Cherry-Goat Slam-HA constructed in Example 1;
[0036] B is a map of the lentiviral vector plasmid CD513B-Cherry-Giraffe Slam-HA constructed in Example 1;
[0037] C is a map of the lentiviral vector plasmid CD513B-Cherry-WTD Slam-HA constructed in Example 1;
[0038] D is a map of the lentiviral vector plasmid CD513B-Cherry-JMD Slam-HA constructed in Example 1;
[0039] E is a map of the lentiviral vector plasmid CD513B-Cherry-CFMD Slam-HA constructed in Example 1;
[0040] F is a map of the lentiviral vector plasmid CD513B-Cherry-ProngHorn Slam-HA constructed in Example 1.
[0041] Figure 2 This is a gel image of PCR identification of the lentiviral vector plasmid bacterial solution obtained in Example 1 of the present invention, + is a positive control, i.e., the SLAM gene gel recovery fragments of various species, - is a negative control, i.e., water;
[0042] In the figure, A is the monoclonal colony PCR identification result of lentiviral vector plasmid CD513B-Cherry-Goat Slam-HA and CD513B-Cherry-Giraffe Slam-HA, wherein M1 represents marker D2000, lanes 1-5 represent five repeats of lentiviral vector plasmid CD513B-Cherry-Goat Slam-HA as a sample, and lanes 6-12 represent seven repeats of lentiviral vector plasmid CD513B-Cherry-Giraffe Slam-HA as a sample;
[0043] B is the result of PCR identification of monoclonal colonies of the lentiviral vector plasmid CD513B-Cherry-WTD Slam-HA, wherein M1 represents marker D2000, and lanes 1-10 represent the repeats of the lentiviral vector plasmid CD513B-Cherry-WTD Slam-HA;
[0044] C is the result of PCR identification of monoclonal colonies of the lentiviral vector plasmid CD513B-Cherry-JMD Slam-HA, wherein lanes 1-13 represent the repeats of the lentiviral vector plasmid CD513B-Cherry-JMD Slam-HA, and M2 represents marker D2000 plus;
[0045] D is the monoclonal colony PCR identification result of the lentiviral vector plasmids CD513B-Cherry-ProngHorn Slam-HA and CD513B-Cherry-CFMDSlam-HA, wherein lanes 1-5 represent the repeats of the lentiviral vector plasmid CD513B-Cherry-ProngHorn Slam-HA, M2 represents marker D2000 plus, and lanes 6-8 represent the repeats of the lentiviral vector plasmid CD513B-Cherry-CFMD Slam-HA.
[0046] Figure 3 This is a fluorescence image of Cherry expression after the lentiviral vector plasmid constructed in Example 1 and the helper plasmid were co-transfected into 293T cells.
[0047] Figure 4 This is a positive clone after subcloning of the SLAM cell line obtained in Example 1 of the present invention.
[0048] Figure 5 Western Blot was used to identify the SLAM expression of the SLAM cell line constructed in Example 1.
[0049] Figure 6 The SLAM expression of the SLAM cell line constructed and obtained in Example 1 was identified by IFA.
[0050] Figure 7 The cytopathic fluorescence images are generated after rPPRV-GFP infected different 293T-SLAM cell lines constructed in Example 1.
[0051] Figure 8 The proliferation of rPPRV-GFP on different 293T-SLAMs constructed in Example 1 was observed using a fluorescence microscope.
[0052] Fig. 9 To evaluate the proliferation of rPPRV-GFP on different 293T-SLAMs constructed in Example 1 using TCID50;
[0053] In the figure, A indicates that the supernatant of each cell line was collected at 24h, 48h, 72h, and 96h to determine the titer of rPPRV-GFP;
[0054] B: 72h after infection, the cells were frozen and thawed twice and then the rPPRV-GFP titer of each cell line was measured. DETAILED DESCRIPTION
[0055] The specific embodiments of the present invention are described in detail below, but it should be understood that the protection scope of the present invention is not limited by the specific embodiments. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention. The experimental methods described in the embodiments of the present invention are conventional methods unless otherwise specified, and the materials, reagents, etc. used in the following embodiments can be obtained from commercial channels unless otherwise specified.
[0056] Example 1: Construction of 293T cells stably expressing SLAM from different families of ruminants.
[0057] 1. Experimental Materials and Instruments
[0058] 1. Cells, plasmids and antibodies
[0059] 293T cells were stored in our laboratory. Plasmid CD513B-Cherry and auxiliary plasmids pMDLg / pRRE, pRSV-Rev, and pMD2.G used to construct lentiviral vectors were also stored in our laboratory. HA, β-Tubulin, and Cherry protein-specific antibodies were purchased from Cell Signaling Technology (CST) and Wuhan Sanying Biotechnology.
[0060] 2. Main reagents
[0061] Various restriction endonucleases and T4 ligase were purchased from NEB, USA; transfection reagent TurboFectTM Transfection Reagent was purchased from Thermo Fisher Scientific; Opti-MEM medium, fetal bovine serum, and DMEM medium were purchased from Gibco; PrimerSTAR MAX high-fidelity polymerase was purchased from TaKaRa Biotechnology Co., Ltd.; DNA gel recovery kit and plasmid mini-extraction kit were purchased from OMEGA.
[0062] 3. Main instruments
[0063] Clean bench (BIOBASE BBS-DDC, Jinan); UV gel imager (Syngene, UK); protein electrophoresis instrument (Jinan Junyi Dongfang); inverted fluorescence microscope (OLYMPUSDP80); high pressure steam sterilizer (Shanghai Boxun); ordinary PCR instrument (Bio-Tech TC-XP).
[0064] 2. Experimental Methods
[0065] 1. Acquisition of target genes
[0066] Ruminants include chevaux, giraffidae, musk deer, deer, pronghorn antelope and bovines. Select a representative animal from each family, Java Mouse Deer (Java Mouse Deer, JMD), Giraffe (Giraffe), Chinese Forest Musk Deer (Chinese Forest Musk Deer, CFMD), White Tailed Deer (White Tailed Deer, WTD), American Antelope (Prong Horn, PH) and Goat (Goat), download the SLAM gene of the above six species from the ruminant full gene database (as shown in Table 1), and the amino acid sequence of the six species SLAM protein is shown in Table 2. Due to the lack of specific antibodies for SLAM of these species, the present invention introduces the sequence of the HA tag at the 3' end of the SLAM gene, which is recorded as the SLAM-HA gene, which is convenient for subsequent identification. The sequence is sent to Beijing Qingke Biotechnology Co., Ltd. for synthesis.
[0067] Table 1 Nucleotide sequences of SLAM proteins in six species
[0068]
[0069]
[0070]
[0071] Table 2 Amino acid sequences of SLAM proteins from six species
[0072]
[0073]
[0074] 2. Construction of lentiviral vector plasmid CD513B-Cherry-SLAM HA
[0075] Primers were designed according to the six target genes and vector nucleotide sequences. First, three fragments required for fusion PCR were amplified, namely fragment 1, fragment 2 and fragment 3. Fragment 1 was denoted as F1, fragment 2 was denoted as F2, and fragment 3 was denoted as F3. Fragment 1 was the sequence between the SgrAI restriction site and T2A of the CD513B-Cherry vector, and fragment 3 was the fragment between the cherry gene and KpnI (the position of T2A in the vector was between the Cherry gene and SLAM-HA). Fragment 2 is the SLAM-HA gene of ruminants, selected from any one of Goat-F2, Giraffe-F2, WTD-F2, JMD-F2, PH-F2 and CFMD-F2. The fusion fragment (SLAM-HA) containing the restriction sites is connected to the lentiviral vector CD513B-Cherry using fusion PCR technology and two restriction sites of SgrAI and KpnI, and DH5α competent cells are transformed. Monoclonal colonies are picked for bacterial liquid PCR identification, and plasmids are extracted from positive bacterial liquid and sent to Beijing Qingke Biotechnology Co., Ltd. for sequencing. The correctly sequenced lentiviral vector plasmids are named CD513B-Cherry-JMD Slam-HA, CD513B-Cherry-Giraffe Slam-HA, CD513B-Cherry-CFMD Slam-HA, CD513B-Cherry-WTD Slam-HA, CD513B-Cherry-ProngHorn Slam-HA, CD513B-Cherry-Goat Slam-HA. In these vectors, SLAM is linked to the Cherry gene through T2A. In theory, the expression of Cherry will also express SLAM, which is convenient for the subsequent screening of positive cells. The vector maps of the six lentiviral vectors constructed are shown in Figure 2. Figure 1 The specific construction steps are as follows:
[0076] (1) Primer design
[0077] The SLAM sequences of six ruminants from different families, including Java Mouse Deer (JMD), Giraffe (Giraffe), Chinese Forest Musk Deer (CFMD), White Tailed Deer (WTD), Prong Horn (PH) and Goat (Goat), were analyzed. Specific primers were designed according to the CD513B-Cherry restriction site of the lentiviral vector, in which the upstream primer of fragment 1 introduced the SgrAI restriction enzyme site, fragment 2 was the SLAM-HA gene of six ruminants, and the downstream primer of fragment 3 introduced the KpnI restriction enzyme site. The target gene was cloned by fusion PCR, and the primers were sent to Xi'an Qingke Biological Co., Ltd. for synthesis. The primer information is shown in Table 3.
[0078] Table 3 Primer sequences
[0079]
[0080] (2) Amplification and fusion of fragments 1, 2, and 3
[0081] Using CD513B-Cherry as a template, the upstream primer shown in SEQ ID NO.13 and the downstream primer shown in SEQ ID NO.14 were used to amplify fragment 1; using the SLAM-HA genes of various ruminants as templates, the primers shown in SEQ ID NO.17-SEQ ID NO.28 in Table 3 were used to amplify fragments 2 of different ruminants, i.e., SLAM-HA genes of different ruminants; when the ruminant is a Javan mouse deer, the primer pair for amplifying its SLAM-HA target gene is shown in SEQ ID NO.23-SEQ ID NO.24; when the ruminant is a giraffe, the primer pair for amplifying its SLAM-HA target gene is shown in SEQ ID NO.19-SEQ ID NO.20; when the ruminant is a forest musk deer, the primer pair for amplifying its SLAM-HA target gene is shown in SEQ ID NO.27-SEQ ID NO.28; when the ruminant is a white-tailed deer, the primer pair for amplifying its SLAM-HA target gene is shown in SEQ ID NO.21-SEQ ID NO.22; when the ruminant is an American antelope, the primer pair for amplifying its SLAM-HA target gene is shown in SEQ ID NO.25-SEQ ID NO.26; when the ruminant is a goat, the primer pair for amplifying its SLAM-HA target gene is shown in SEQ ID NO.17-SEQ ID NO.18.
[0082] Using CD513B-Cherry as a template, the upstream primer shown in SEQ ID NO.15 and the downstream primer shown in SEQ ID NO.16 were used to amplify fragment 3.
[0083] Using fragment 1, fragment 2, and fragment 3 as templates, the fusion fragment was amplified using fusion PCR technology with the upstream primer shown in SEQ ID NO. 13 and the downstream primer shown in SEQ ID NO. 16. The amplification system is shown in Table 4, and the amplification program is shown in Table 5.
[0084] Table 4 PCR amplification system
[0085] Components volume PrimerSTAR MAX DNA Polymerase (2×) 20μL Upstream primer F (10 μM) 1μL Downstream primer R (10 μM) 1μL template 1μL ddH2O 17μL Total volume 40μL
[0086] Table 5 PCR program
[0087]
[0088] 3. PCR identification of lentiviral vector plasmid
[0089] The results are as follows Figure 2 As shown, the target gene SLAM-HA was successfully connected to the lentiviral vector plasmid CD513B-Cherry. The lentiviral vector plasmids CD513B-Cherry-JMD Slam-HA, CD513B-Cherry-Giraffe Slam-HA, CD513B-Cherry-CFMD Slam-HA, CD513B-Cherry-WTD Slam-HA, CD513B-Cherry-ProngHorn Slam-HA and CD513B-Cherry-Goat Slam-HA were obtained. The vector maps of the six lentiviral vector plasmids are shown in Figure 1 shown.
[0090] 4. Packaging of Lentiviral Vector Plasmid
[0091] The constructed lentiviral vector plasmids CD513B-Cherry-JMD Slam-HA, CD513B-Cherry-Giraffe Slam-HA, CD513B-Cherry-CFMD Slam-HA, CD513B-Cherry-WTDSlam-HA, CD513B-Cherry-ProngHorn Slam-HA and CD513B-Cherry-Goat Slam-HA expressing the above six species SLAM were mixed with the auxiliary plasmids pMDLg / pRRE, pRSV-Rev and pMD2.G in the ratio of 3:1:1:1, and then transfected into 293T cells respectively.
[0092] The specific process is as follows: 293T cells are evenly plated in a 24-well cell plate and transfected when the density reaches 80%. The recombinant plasmids CD513B-Cherry-JMD Slam-HA, CD513B-Cherry-Giraffe Slam-HA, CD513B-Cherry-CFMD Slam-HA, CD513B-Cherry-WTD Slam-HA, CD513B-Cherry-ProngHorn Slam-HA and CD513B-Cherry-Goat Slam-HA are mixed with auxiliary plasmids pMDLg / pRRE, pRSV-Rev, pMD2.G in a ratio of 3:1:1:1 to obtain a 3ug plasmid mixture, and then the plasmid mixture is mixed with 6μL transfection reagent TurboFact, incubated for 15min, the cell culture medium is discarded, 300μL serum-free Opti-MEM medium is added to wash twice, and then 1mL 2% FBSDMEM is added. The incubated plasmid mixture was gently and evenly added to the cell wells and placed in a cell culture incubator. Lentivirus packaging solution was added 16 h after transfection and cultured for 72 h. 1 mL of cell supernatant was collected and centrifuged at 4 °C for 10 min. The supernatant was collected to obtain six types of packaged SLAM lentiviruses.
[0093] The six SLAM-expressing lentiviral vectors constructed were co-transfected with the auxiliary plasmid into 293T cells, and the expression of Cherry in the cells was observed under a fluorescence microscope 72 hours later. Figure 3 As shown, 293T cells successfully expressed the Cherry protein of the lentivirus, indicating that the lentivirus was packaged.
[0094] 5. Lentiviral transduction and screening of positive cells
[0095] The 293T cells with good growth status were evenly spread on a 6-well cell culture plate. After 12 hours, the confluence reached about 60%. The supernatant was discarded, and the six SLAM lentiviruses prepared in the previous step were mixed with DMEM medium containing 10% fetal bovine serum at a mass fraction of 1mL:1mL, and Polybrene (hexadimethrine bromide) was added at 1:5000. After gentle mixing, it was added to the 6-well cell culture plate. 72h after transduction, the medium was replaced with a 10-fold screening concentration (30μg / mL), and the medium was changed every 3 days. After 6 days, it was replaced with a complete medium with a normal screening concentration (3μg / mL), and the medium was changed every 3 days. After 9 days, it was determined that the cells in the infected group were full according to the expression of Cherry in the cells under a fluorescence microscope, and all the cells in the control group had died. The cells were digested and counted, and the cells were diluted to a concentration of 10 / mL, and then spread on a 96-well cell plate, and 100μL of cell dilution was added to each well, so that each well contained only one cell. The 96-well plate was placed at 37°C and 5% CO 2 The cells were cultured in a cell culture incubator, and the culture medium was replenished every 3 days. The cells were observed under a microscope for about 12 days. The cells were digested with trypsin and then spread on a 24-well plate for expansion culture. After the cells were full, they were subcultured and Western Blot and indirect immunofluorescence were performed to identify the expression of cell SLAM protein (the control group was 293T-Cherry). One positive clone was selected for each 293T-SLAM cell line for subculture. The 293T cells expressing the six species SLAM were named 293T-Goat SLAM, 293T-Giraffe SLAM, 293T-WTDSLAM, 293T-JMD SLAM, 293T-PH SLAM, and 293T-CFMD SLAM, and the cells were frozen.
[0096] 6. Determination of the minimum killing concentration of puromycin for 293T cells
[0097] 293T cells were inoculated in a 24-well plate, cultured to 80% cell density with DMEM medium containing 10% fetal bovine serum by mass fraction, and then cultured with DMEM medium containing different concentration gradients of puromycin and 2% fetal bovine serum by mass fraction. The concentrations of different puromycin concentrations were: 0μg / mL, 1μg / mL, 2μg / mL, 3μg / mL, 4μg / mL, 5μg / mL, 6μg / mL, 7μg / mL, 8μg / mL, 9μg / mL, 10μg / mL. Three replicates were made for each concentration, and the culture medium was changed daily for 4 consecutive days. The lowest puromycin concentration in the culture medium in which all cells died after 4 days of culture was the optimal puromycin screening concentration. The results showed that all cells died in the culture medium with a concentration of 3μg / mL on the 4th day, so the lowest lethal puromycin concentration of 293T was determined to be 3μg / mL, which was the screening concentration of positive cells.
[0098] 7. Western Blot specific steps:
[0099] (1) Collecting protein samples: Six strains of 293T-SLAM expressing different ruminant SLAM were plated in a 12-well plate. When the cell density grew to more than 90%, the cell protein was collected. In order to prevent protein degradation, protease inhibitors were added to the cell lysis buffer, the liquid in the wells of the cell samples to be collected was discarded, PBS was washed twice, 80 μL of lysis buffer containing PMSF was added, and all cells were lysed into a fluid state and collected into an EP tube. Lysis was carried out on ice for 10 min, and then 20 μL of 1× protein loading buffer was added, and the cells were boiled in a 100°C metal bath for 10 min.
[0100] (2) Electrophoresis: Prepare a 10% protein separation gel. Use a pipette to load 10 μL of sample into the well and add an appropriate amount of protein marker. Use 80V and 120V voltages for electrophoresis of the concentration gel and separation gel, respectively. Stop the electrophoresis when bromophenol blue reaches the bottom of the gel.
[0101] (3) Transfer: The PVDF membrane must be activated with methanol for 1 min before use. The protein glue is applied to the activated PVDF membrane and the membrane is transferred in the direction of negative electrode-protein glue-PVDF membrane-positive electrode. After the clamps are fixed, the membrane is placed in the transfer tank and pre-cooled transfer solution is added. The transfer tank is placed in an ice bath, and the constant current is set to 100 mA. The transfer time is 2 h.
[0102] (4) Blocking: After the transfer is completed, place the PVDF membrane in the blocking solution for blocking. Place the box containing the blocking solution on a decolorizing shaker and shake slowly. After blocking for 2 hours, use TBST to wash away the blocking solution.
[0103] (5) Primary antibody incubation: Dilute the primary antibody to an appropriate working concentration with TBST. Place the PVDF membrane with the transferred protein in the corresponding primary antibody (the antibodies used include HA, Cherry and β-Tubulin specific antibodies) and incubate overnight at 4°C. After the incubation, recover the primary antibody. Add TBST and wash on a shaker at 80 r / min for 6 to 8 minutes. Discard the washing solution, add TBST and wash for 8 minutes. Repeat the washing 5 times.
[0104] (6) Secondary antibody incubation: Select the corresponding secondary antibody according to the primary antibody, dilute the secondary antibody to an appropriate working concentration with TBST, place the membrane in the secondary antibody, and incubate on a shaker for 1 h at room temperature. After incubation, recover the secondary antibody. Add TBST, shake on a shaker at 80 r / min for 8 min, discard the washing solution, add TBST and wash for 8 min, and repeat the washing 5 times.
[0105] (7) Protein detection: Prepare ECL luminescent solution for color development and expose in an imaging system.
[0106] Indirect immunofluorescence assay (IFA) specific steps:
[0107] When the density of 293T-SLAM cells in the 96-well plate cultured overnight reaches 80%, IFA is performed, and the HA protein rabbit monoclonal antibody is selected to detect the expression of SLAM, and the secondary antibody is selected as goat anti-rabbit IgG labeled with 488 fluorescent label. The specific steps are as follows:
[0108] (1) Fixation: discard the culture medium, wash twice with PBS, add 50 μL of 4% paraformaldehyde to the wells and cover the cells. Do not let the cells dry. After fixation for about 30 min, discard the paraformaldehyde and wash three times with PBS.
[0109] (2) Permeabilization: discard PBS, add 50 μL 0.2% Triton X-100 solution to treat the cells for 5 min, discard the liquid, and wash the cells with PBS;
[0110] (3) Blocking: Discard PBS, add 50 μL of pre-prepared 1% BSA and place in a 37°C incubator for blocking for 30 min;
[0111] (4) Incubation with primary antibody: Use 1% BSA to dilute the primary antibody to the working concentration according to the instructions of the monoclonal antibody, discard the BSA in the previous step, add 40 μL of primary antibody, and incubate in a 4°C refrigerator overnight;
[0112] (5) Washing: Wash the cells 5 times with PBS and gently shake the cell plate, each time for 5 min to wash away the unbound primary antibody;
[0113] (6) Incubation with secondary antibody: Dilute the fluorescent secondary antibody to the working concentration using 1% BSA, add 50 μL to the cell wells, wrap the cell plate with tin foil to avoid light, and incubate in a 37°C incubator for 1 h;
[0114] (7) Washing: Discard the secondary antibody solution, wash the cells 5 times with PBS and gently shake the cell plate, each time for 5 minutes to wash away the unbound secondary antibody;
[0115] (8) Staining cell nuclei: dilute Hoechst33342 solution at 1:500 to the working concentration, add 50 μL into the cell wells, and incubate in the dark for 15 min;
[0116] (9) Washing: Discard the Hoechst33342 solution, use PBS and gently shake the cell plate to wash the cells three times, each time for 2 min, and finally add 50 μL PBS into the wells;
[0117] (10) Observe the luminescence under an inverted fluorescence microscope and determine the gene expression status by comparing it with the control group.
[0118] Example 2: Application of the constructed 293T cells stably expressing ruminant SLAM.
[0119] 1. Experimental Materials
[0120] (1) The 293T cells stably expressing SLAM of different families of ruminants prepared in Example 1, namely, the 293T-SLAM cell lines: 293T-Goat SLAM, 293T-Giraffe SLAM, 293T-WTD SLAM, 293T-JMD SLAM, 293T-PHSLAM, 293T-CFMD SLAM.
[0121] (2) The construction process of 293T-Cherry cell line is as follows: lentiviral vector plasmid CD513B-Cherry and auxiliary plasmids pMDLg / pRRE, pRSV-Rev, and pMD2.G were mixed at a ratio of 3:1:1:1 to obtain 3ug of plasmid mixture, and the plasmid mixture was then mixed with 6μL of transfection reagent TurboFact. After incubation, the cell culture medium was discarded, 300μL of serum-free Opti-MEM culture medium was added to wash twice, and then 1mL of 2% FBS DMEM was added. The incubated plasmid mixture was gently and evenly added to the cell wells. Lentivirus packaging solution was added 16h after transfection, and cultured for 72h. 1mL of cell supernatant was collected, centrifuged at 4℃ for 10min, and the supernatant was collected to obtain the packaged Cherry lentivirus. 293T cells with good growth status were evenly spread on 6-well cell culture plates. After 12 hours, the confluence reached about 60%. The supernatant was discarded, and the Cherry lentivirus prepared in the previous step was mixed with DMEM medium containing 10% fetal bovine serum at a mass fraction of 1mL:1mL, and Polybrene (hexadimethrine bromide) was added at 1:5000. After gentle mixing, it was added to the 6-well cell culture plate. 72h after transduction, the medium was replaced with 10 times the screening concentration (30μg / mL), and the medium was changed every 3 days. After 6 days, it was replaced with complete medium with normal screening concentration (3μg / mL), and the medium was changed every 3 days. After 9 days, it was determined that the cells in the infected group were full according to the expression of Cherry in the cells under a fluorescence microscope, and all the cells in the control group had died. The cells were digested and counted, and the cells were diluted to a concentration of 10 / mL, and then spread on a 96-well cell plate. 100μL of cell dilution was added to each well, so that each well contained only one cell. The 96-well plate was placed in a 37°C, 5% CO2 cell culture incubator for culture, and the culture medium was replenished every 3 days. The plate was observed under a microscope after about 12 days, and the wells in which each cell expressed Cherry protein and had only one cell cluster were selected. After digestion with trypsin, the wells were spread on 24-well plates for expansion culture. After the cells were fully grown, they were subcultured to obtain the 293T-Cherry cell line.
[0122] (3) rPPRV-GFP is a recombinant virus rescued by using the PPRV reverse genetics system established in the laboratory's previous research. The specific construction method is as follows:
[0123] First, RNA of PPRV vaccine strain Nigeria / 75 / 1 was extracted according to the instructions of Trizol RNAiso Plus reagent, and then the instructions of StarScript II First-strand cDNA Synthesis Mix were reversed to obtain cDNA. PCR was carried out using cDNA as a template, and the obtained full genome fragment was connected to the pCMV-add vector (the pCMV-add vector is a pBluescript SK plasmid as a skeleton, T7 promoter is replaced by CMV promoter, and HDVribozyme sequence is introduced to obtain), thereby obtaining a recombinant plasmid pT7-PPRV comprising the full genome of PPRV Nigeria / 75 / 1. On this plasmid basis, a green fluorescent protein (GFP) gene was inserted between P and M genes to construct the PPRV full-length plasmid pT7-PPRV-GFP of the chimeric GFP gene. Using plasmid pT7-PPRV as a template, the PPRV Nigeria / 75 / 1 nucleoprotein (NP), phosphoprotein (P), and large polymerase protein (L) gene sequences were amplified, and the amplified fragments were cloned into the pCI-neo eukaryotic expression plasmid to obtain the auxiliary plasmid PPRV-NPL. The three plasmids pT7-PPRV-GFP, PPRV-NPL, and pCAGGS-T7 (which was obtained by cloning the T7RANA polymerase sequence into the pCAGGS eukaryotic vector) were co-transfected into BHK21 cells at a mass ratio of 2:2:1, and the cells were observed under a fluorescence microscope until the cells expressed a large amount of GFP and produced cytopathic effects, i.e., the rPPRV-GFP strain was obtained.
[0124] 2. Experimental Methods
[0125] 1. Observation of the cytopathic effects of the six 293T-SLAM cells obtained in Example 1 infected with rPPRV-GFP
[0126] The six strains of 293T-SLAM cells obtained in Example 1 were respectively plated in a 24-well plate. When the cell density grew to 90%, the culture medium was discarded, and the cells were washed twice with pure DMEM culture medium. rPPRV-GFP was diluted with an infection index of 2MOI, added to the cell wells, and incubated in a 37°C incubator. The plate was shaken once every 30 minutes. After 2 hours, the virus solution was discarded and replaced with DMEM culture medium containing 2% fetal bovine serum. The virus GFP expression and the size of the syncytium produced by the cells were observed under a microscope 48 hours after infection. At the same time, 293T-Cherry cells were used as a control group.
[0127] The results are as follows Figure 7As shown, after infection, microscopic observation revealed that 293T-Cherry could not form syncytia, but cells expressing SLAM fused with each other to form obvious syncytia.
[0128] 2. Proliferation of rPPRV-GFP on six 293T-SLAM cell lines
[0129] 1 mol rPPRV-GFP was inoculated into the six SLAM-293T cells constructed in Example 1 respectively, and the cells were cultured in 1 mL of DMEM medium containing 2% fetal bovine serum. 100 μL of supernatant was collected every 24 hours after infection to measure TCID50 (half tissue culture infection dose), and 100 μL of culture medium was added to the cell wells at the same time, and the collection was continued until 96 hours. The expression of viral GFP was observed under a fluorescence microscope at each time point. The specific steps for determining TCID50 were as follows: the DogSLAM-Vero cells constructed in the early stage of the laboratory were cultured at 1×10 4 The cells were inoculated into a 96-well plate at a density of 100 / well and cultured overnight. The collected viral supernatant was diluted ten-fold in a sterilized 1.5 mL centrifuge tube with pure MEM, starting from 10 -1 to 10 -10 , inoculated in a 96-well plate, 3 wells for each concentration gradient, 100 μL in each well, and a blank control group inoculated with only pure MEM was set up. After culturing in a 37°C incubator for 4 days, the viral GFP expression was observed under an inverted fluorescence microscope, and the TCID50 of rPPRV-GFP was calculated according to the Reed-Muench method and the growth curve was drawn. 293T-Cherry cells were used as the control group.
[0130] The results are as follows Figure 8 As shown in the figure, although 293T-Cherry cells showed green fluorescence after infection and increased at 72h, the fluorescence intensity was much lower than that of the six SLAM cell lines, and no obvious syncytia were produced. Fig. 9 As shown, after PPRV infection, the virus titer of 293T-Cherry cells was only 1×10 3.75 TCID50 / mL, however, in the cell line expressing SLAM, the virus titer reached 1×10 5 TCID50 / mL or above, with 293T-Cherry-JMD titer as high as 1×10 5.75 TCID50 / mL, the virus titer is 100 times that of 293T-Cherry cells.
[0131] In summary, the present invention provides the amino acid sequence of SLAM protein of Java mouse deer, giraffe, forest musk deer, white-tailed deer, American antelope and goat. Cell lines stably expressing SLAM of Java mouse deer, giraffe, forest musk deer, white-tailed deer, American antelope and goat are constructed. The efficiency of SLAM-mediated PPRV infection and proliferation of Java mouse deer, giraffe, forest musk deer, white-tailed deer, American antelope and goat is explained. Its advantage is that compared with cells that do not express SLAM, HEK-293T expressing these 6 kinds of ruminant SLAM can obviously mediate the infection and proliferation of PPRV, one PPRV causes the pathological change time of 293T-Slam cell line more obviously than that of 293T-Cherry cell, and the second 293T-Slam cell line has a virus titer that is about 100 times higher than that of 293T-Cherry cell. Moreover, the lentiviral system is used to stably integrate the ruminant Slam gene into the 293T cell genome chromosome, making it genetically stable and not easily lost. In addition, the constructed 293T-Slam cell line grows fast and is easy to culture. In addition to meeting the small-scale use required for scientific research, it can also meet the large-scale use in vaccine production.
[0132] Although preferred embodiments of the present invention have been described, additional changes and modifications may occur to these embodiments once those skilled in the art are aware of the basic inventive concepts.
[0133] Obviously, those skilled in the art may make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims
1. A method for constructing a 293T cell line stably expressing ruminant SLAM protein, characterized in that: The steps include: Download the SLAM gene of the desired ruminant from the ruminant gene database, introduce the HA tag at the 3' end of the SLAM gene to obtain the SLAM-HA target gene, then connect the SLAM-HA target gene to the CD513B-Cherry lentiviral vector, transform DH5α competent cells, extract the positive plasmid to obtain the lentiviral vector plasmid; The CD513B-Cherry lentiviral vector construction process is: replacing the GFP fluorescent reporter gene of the CD513B plasmid with the Cherry fluorescent reporter gene, and adding the HTLV promoter in front of the Cherry gene to obtain the CD513B-Cherry lentiviral vector; The obtained lentiviral vector plasmid was mixed with auxiliary plasmids pMDLg / pRRE, pRSV-Rev, and pMD2.G, and co-transfected into 293T cells to obtain packaged SLAM lentivirus; A human renal epithelial cell line stably expressing ruminant SLAM protein was obtained by transducing SLAM lentivirus into human renal epithelial cells.
2. The method for constructing a 293T cell line stably expressing a ruminant SLAM protein according to claim 1, characterized in that: The construction process of the lentiviral vector plasmid is as follows: using the lentiviral vector CD513B-Cherry as a template, amplifying fragment 1 with the upstream primer shown in SEQ ID NO.13 and the downstream primer shown in SEQ ID NO.14; amplifying fragment 3 with the upstream primer shown in SEQ ID NO.15 and the downstream primer shown in SEQ ID NO.16; Then, the fragment 1, the SLAM-HA target gene and the fragment 3 were fused by using the fusion PCR technology, so that the SLAM-HA target gene was connected to the lentiviral vector CD513B-Cherry, and the DH5α competent cells were transformed, and the positive plasmid was extracted to obtain the lentiviral vector plasmid.
3. The method for constructing a 293T cell line stably expressing a ruminant SLAM protein according to claim 2, characterized in that: The ruminant is any one of Java mouse deer, giraffe, forest musk deer, white-tailed deer, American antelope and goat.
4. The method for constructing a 293T cell line stably expressing a ruminant SLAM protein according to claim 3, characterized in that: The SLAM gene sequence of the Javan mouse deer is shown in SEQ ID NO.1, and the amino acid sequence of the protein encoded by the SLAM gene is shown in SEQ ID NO.7; The SLAM gene sequence of the giraffe is shown in SEQ ID NO.2, and the amino acid sequence of the protein encoded by it is shown in SEQ ID NO.8; The SLAM gene sequence of the forest musk deer is shown in SEQ ID NO.3, and the amino acid sequence of the protein encoded by it is shown in SEQ ID NO.9; The SLAM gene sequence of the white-tailed deer is shown in SEQ ID NO.4, and the amino acid sequence of the protein encoded by it is shown in SEQ ID NO.10; The SLAM gene sequence of the American antelope is shown in SEQ ID NO.5, and the amino acid sequence of the protein encoded by it is shown in SEQ ID NO.11; The goat SLAM gene sequence is shown as SEQ ID NO.6, and the amino acid sequence of the protein encoded by the gene is shown as SEQ ID NO.
12.
5. The method for constructing a 293T cell line stably expressing a ruminant SLAM protein according to claim 3, characterized in that: When the ruminant is Java mouse deer, the primer pair for amplifying its SLAM-HA target gene is shown as SEQ ID NO.23-SEQ ID NO.24; When the ruminant is a giraffe, the primer pair for amplifying its SLAM-HA target gene is shown as SEQ ID NO.19-SEQ ID NO.20; When the ruminant is musk deer, the primer pair for amplifying its SLAM-HA target gene is shown in SEQ ID NO.27-SEQ ID NO.28; When the ruminant is a white-tailed deer, the primer pair for amplifying its SLAM-HA target gene is shown as SEQ ID NO.21-SEQ ID NO.22; When the ruminant is an American antelope, the primer pair for amplifying its SLAM-HA target gene is shown as SEQ ID NO.25-SEQ ID NO.26; When the ruminant is a goat, the primer pair for amplifying its SLAM-HA target gene is shown as SEQ ID NO.17-SEQ ID NO.
18.
6. The method for constructing a 293T cell line stably expressing a ruminant SLAM protein according to claim 1, characterized in that: The SLAM lentivirus packaging process is as follows: the obtained lentiviral vector plasmid is mixed with the auxiliary plasmids pMDLg / pRRE, pRSV-Rev, and pMD2.G at a ratio of 3:1:1:1 to obtain a plasmid mixture, and the plasmid mixture is then mixed with the transfection reagent TurboFact and incubated, and then the cell culture medium is discarded, washed with serum-free Opti-MEM culture medium, and then 1 mL of 2% FBSDMEM is added, and the incubated plasmid mixture is transfected and packaged and cultured, the culture fluid is collected, centrifuged, and the supernatant is collected to obtain the packaged SLAM lentivirus.
7. The method for constructing a 293T cell line stably expressing a ruminant SLAM protein according to claim 6, characterized in that: The usage ratio of the plasmid mixture to the transfection reagent TurboFact is 3ug:6μL.
8. The method for constructing a 293T cell line stably expressing a ruminant SLAM protein according to claim 6, characterized in that: The centrifugation conditions were: 4°C for 10 min.
9. A SLAM lentivirus, characterized in that: Obtained by the method according to claim 6.
10. Use of the SLAM lentivirus according to claim 9 in the preparation of a PPR diagnostic reagent and / or vaccine.
Citation Information
Patent Citations
Canine distemper virus (CDV) sensitive cell line and establishment method and application thereof
CN102807970A
